Powered by: Motilal Oswal
2025-07-10 11:38:05 am | Source: Accord Fintech
Veerhealth Care gains on entering into contract manufacturing agreement with Leading Marketplace Company
Veerhealth Care gains on entering into contract manufacturing agreement with Leading Marketplace Company

Veerhealth Care is currently trading at Rs. 20.02, up by 0.01 points or 0.05% from its previous closing of Rs. 20.01 on the BSE.

The scrip opened at Rs. 19.85 and has touched a high and low of Rs. 20.50 and Rs. 19.85 respectively. So far 6138 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 27.00 on 26-Jul-2024 and a 52 week low of Rs. 9.29 on 04-Mar-2025.

Last one week high and low of the scrip stood at Rs. 21.20 and Rs. 19.31 respectively. The current market cap of the company is Rs. 40.04 crore.

The promoters holding in the company stood at 31.50%, while non-institutions held 68.50% stake in the company.

Veerhealth Care has entered into a strategic contract manufacturing agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products. 

Under the terms of the agreement, the company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. The company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon. This development is expected to have a positive impact on the company's revenue and capacity utilization in the coming quarters.

Veerhealth Care is engaged mainly in business of trading and manufacturing and marketing research based ayurvedic medicines.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here